Tech Company Financing Transactions

Neotropix Funding Round

Aurora Funds, Quaker Partners and VIMAC Ventures invested in a $10 million Series A funding round for Neotropix. The financing round was announced by the company on 12/13/2004.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

351 Phoenixville Pike
Malvern, PA 19355
USA

Phone

(610) 296-8660

Website

www.neotropix.com

Email Address

[email protected]

Overview

Neotropix is an early stage drug discovery company dedicated to the research, development and commercialization of virus-based therapies for the treatment of cancer. Founded in 2003, Neotropix is developing oncolytic virotherapies to treat several of the most aggressive and deadly forms of cancer.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Peter Lanciano

        

Chief Scientific Officer

Paul Hallenbeck

        

Browse more venture capital transactions:

Prev: 12/13/2004: QuatRx Pharmaceuticals venture capital transaction
Next: 12/14/2004: TeleCIS Wireless venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary